ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| ICER's work on low-risk prostate cancer highlighted at The Health Management Academy CMO Forum |
|
Donald E. Casey Jr., MD, MPH presented ICER's work on the primary management options for low-risk prostate cancer at the Chief Medical Officers (CMO) Forum of The Health Management Academy on April 23, 2010. The presentation was titled "Comparative Effectiveness and Patient Centered Outcomes". |